X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (110456) 110456
Book Review (11858) 11858
Publication (6053) 6053
Newsletter (3439) 3439
Book Chapter (340) 340
Conference Proceeding (249) 249
Magazine Article (115) 115
Dissertation (97) 97
Newspaper Article (86) 86
Book / eBook (36) 36
Government Document (11) 11
Web Resource (11) 11
Data Set (7) 7
Reference (6) 6
Paper (3) 3
Journal / eJournal (2) 2
Trade Publication Article (2) 2
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (94328) 94328
humans (91204) 91204
female (55922) 55922
male (53078) 53078
middle aged (48510) 48510
aged (43605) 43605
adenocarcinoma (41377) 41377
oncology (38703) 38703
cancer (33274) 33274
adult (30706) 30706
adenocarcinoma - pathology (27882) 27882
prognosis (20545) 20545
adenocarcinoma - drug therapy (19843) 19843
surgery (19034) 19034
carcinoma (18075) 18075
aged, 80 and over (16525) 16525
neoplasm staging (15586) 15586
adenocarcinoma - surgery (15462) 15462
chemotherapy (15354) 15354
animals (13097) 13097
treatment outcome (12531) 12531
abridged index medicus (12364) 12364
retrospective studies (12313) 12313
tumors (11885) 11885
metastasis (11524) 11524
adenocarcinoma - therapy (11520) 11520
survival (11490) 11490
research (11113) 11113
care and treatment (10600) 10600
adenocarcinoma - mortality (10181) 10181
analysis (9574) 9574
follow-up studies (9511) 9511
survival rate (9406) 9406
antineoplastic combined chemotherapy protocols - therapeutic use (9236) 9236
adenocarcinoma - secondary (9005) 9005
expression (8961) 8961
mice (8884) 8884
combined modality therapy (8778) 8778
pancreatic cancer (8701) 8701
medicine & public health (8445) 8445
lung neoplasms - pathology (8439) 8439
gastroenterology & hepatology (8370) 8370
therapy (8108) 8108
adenocarcinoma - genetics (8082) 8082
immunohistochemistry (8016) 8016
adenocarcinoma - radiotherapy (8007) 8007
adenocarcinoma - metabolism (7881) 7881
cell line, tumor (7874) 7874
lung cancer (7860) 7860
radiotherapy (7629) 7629
pathology (7620) 7620
health aspects (7100) 7100
adenocarcinoma - diagnosis (6514) 6514
diagnosis (6418) 6418
risk factors (6392) 6392
lymphatic metastasis (6329) 6329
survival analysis (6245) 6245
apoptosis (6123) 6123
lung neoplasms - drug therapy (6020) 6020
genetic aspects (5570) 5570
disease-free survival (5546) 5546
prostatic neoplasms - pathology (5544) 5544
mutation (5515) 5515
pancreatic neoplasms - pathology (5424) 5424
time factors (5347) 5347
antineoplastic agents - therapeutic use (5296) 5296
colorectal cancer (5283) 5283
stomach neoplasms - pathology (5040) 5040
lung neoplasms - genetics (4956) 4956
gene expression (4920) 4920
patients (4881) 4881
prostate cancer (4843) 4843
neoplasm metastasis (4669) 4669
development and progression (4617) 4617
carcinoma, squamous cell - pathology (4580) 4580
cancer therapies (4329) 4329
radiology, nuclear medicine & medical imaging (4308) 4308
medical prognosis (4184) 4184
prospective studies (4183) 4183
proteins (4174) 4174
biopsy (4167) 4167
neoplasm invasiveness (4122) 4122
oncology, experimental (4092) 4092
cell biology (4048) 4048
breast-cancer (4010) 4010
chemotherapy, adjuvant (3935) 3935
fluorouracil - administration & dosage (3907) 3907
respiratory system (3889) 3889
gene expression regulation, neoplastic (3874) 3874
article (3864) 3864
urology & nephrology (3841) 3841
medicine (3766) 3766
obstetrics & gynecology (3749) 3749
stomach cancer (3699) 3699
esophageal cancer (3656) 3656
disease progression (3614) 3614
hematology, oncology and palliative medicine (3613) 3613
esophageal neoplasms - pathology (3605) 3605
metastases (3599) 3599
adenocarcinoma - complications (3525) 3525
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (104811) 104811
Japanese (2671) 2671
German (1930) 1930
French (1792) 1792
Spanish (706) 706
Russian (693) 693
Chinese (637) 637
Italian (476) 476
Polish (211) 211
Hungarian (81) 81
Korean (74) 74
Czech (68) 68
Portuguese (58) 58
Dutch (47) 47
Danish (44) 44
Romanian (42) 42
Bulgarian (32) 32
Turkish (27) 27
Norwegian (25) 25
Croatian (24) 24
Serbian (18) 18
Swedish (16) 16
Finnish (14) 14
Hebrew (14) 14
Ukrainian (14) 14
Slovak (9) 9
Lithuanian (8) 8
Icelandic (4) 4
Greek (3) 3
Persian (3) 3
Afrikaans (2) 2
Bosnian (1) 1
Catalan (1) 1
Georgian (1) 1
Latvian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2013, Volume 85, Issue 1, pp. 101 - 108
Purpose To assess the survival benefit of early vs late salvage hormonal therapy (HT), we performed a secondary analysis on patients who developed recurrence... 
Radiology | Hematology, Oncology and Palliative Medicine | PHASE-III TRIAL | ANDROGEN DEPRIVATION | RELAPSE | ONCOLOGY | DEFINITIVE RADIOTHERAPY | RANDOMIZED-TRIAL | ABLATION | RECURRENCE | SUPPRESSION | CARCINOMA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | ANTIGEN | Neoplasm Recurrence, Local - radiotherapy | Prostatic Neoplasms - radiotherapy | Humans | Middle Aged | Neoplasm Recurrence, Local - drug therapy | Male | Neoplasm Recurrence, Local - mortality | Neoplasm Recurrence, Local - pathology | Time Factors | Antineoplastic Agents, Hormonal - therapeutic use | Prostatic Neoplasms - blood | Neoplasm Recurrence, Local - blood | Prostatic Neoplasms - drug therapy | Adenocarcinoma - radiotherapy | Salvage Therapy - mortality | Prostatic Neoplasms - pathology | Drug Administration Schedule | Adenocarcinoma - blood | Adenocarcinoma - drug therapy | Adenocarcinoma - secondary | Prostate-Specific Antigen - blood | Prostatic Neoplasms - mortality | Analysis of Variance | Neoadjuvant Therapy - methods | Survival Analysis | Aged | Salvage Therapy - methods | Adenocarcinoma - mortality | Medical research | Cancer patients | Care and treatment | Nuclear radiation | Patient outcomes | Adjuvant treatment | Medicine, Experimental | Radiotherapy | Prostate cancer | Cancer | Index Medicus | PROSTATE | MULTIVARIATE ANALYSIS | PATIENTS | HEALTH HAZARDS | FAILURES | METASTASES | CARCINOMAS | RADIOLOGY AND NUCLEAR MEDICINE | ANTIGENS | RADIOTHERAPY | HORMONES
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 2, pp. 187 - 199
Summary Background We aimed to compare overall survival after standard-dose versus high-dose conformal radiotherapy with concurrent chemotherapy and the... 
Hematology, Oncology and Palliative Medicine | ONCOLOGY | COMPETING RISK | CLINICAL-TRIALS | THERAPY ONCOLOGY GROUP | CHEMORADIATION | INDUCTION | CARCINOMA | CHEMOTHERAPY | RADIATION-THERAPY | Prognosis | Follow-Up Studies | Lung Neoplasms - mortality | Humans | Middle Aged | Lung Neoplasms - pathology | Male | Carcinoma, Large Cell - mortality | Radiotherapy, Image-Guided | Chemoradiotherapy | Carcinoma, Large Cell - secondary | Neoplasm Metastasis | Antibodies, Monoclonal, Humanized - administration & dosage | Carcinoma, Non-Small-Cell Lung - secondary | Carcinoma, Squamous Cell - mortality | Aged, 80 and over | Adult | Female | Cetuximab | Paclitaxel - administration & dosage | Radiotherapy Dosage | Carboplatin - administration & dosage | Carcinoma, Squamous Cell - therapy | Survival Rate | Combined Modality Therapy | Lung Neoplasms - therapy | Carcinoma, Non-Small-Cell Lung - mortality | Adenocarcinoma - secondary | Carcinoma, Non-Small-Cell Lung - therapy | Adenocarcinoma - therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Radiotherapy, Conformal | Carcinoma, Squamous Cell - secondary | Aged | Neoplasm Staging | Carcinoma, Large Cell - therapy | Adenocarcinoma - mortality | Antimitotic agents | Care and treatment | Chemotherapy | Dosage and administration | Lung cancer, Non-small cell | Antineoplastic agents | Radiotherapy | Cancer | Index Medicus
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2016, Volume 68, pp. 156 - 162
Abstract Purpose To assess preliminary safety and efficacy results of the anti-programmed cell death ligand-1 (anti-PD-L1) durvalumab in combination with... 
Hematology, Oncology and Palliative Medicine | Immunoradiotherapy | Phase 2 | Phase 1 | Radiotherapy | Anti-PD-L1 | ABSCOPAL | ONCOLOGY | MECHANISMS | PATIENT | RADIATION-THERAPY | Lymphatic Metastasis - radiotherapy | Bone Neoplasms - therapy | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Carcinoma, Transitional Cell - secondary | Radiosurgery | Bone Neoplasms - secondary | Antibodies, Monoclonal - therapeutic use | Lung Neoplasms - pathology | Male | Antineoplastic Agents - therapeutic use | Carcinoma, Transitional Cell - therapy | Liver Neoplasms - therapy | Eye Neoplasms - therapy | Chemoradiotherapy | Small Cell Lung Carcinoma - secondary | Breast Neoplasms - therapy | Brain Neoplasms - secondary | Neoplasms - therapy | Squamous Cell Carcinoma of Head and Neck | Urinary Bladder Neoplasms - pathology | Aged, 80 and over | Adult | Female | Liver Neoplasms - secondary | Colonic Neoplasms - therapy | Eye Neoplasms - pathology | Head and Neck Neoplasms - therapy | Kaplan-Meier Estimate | Carcinoma, Squamous Cell - therapy | Survival Rate | Lung Neoplasms - therapy | Adenocarcinoma - secondary | Melanoma - secondary | Head and Neck Neoplasms - pathology | Disease-Free Survival | B7-H1 Antigen - antagonists & inhibitors | Adenocarcinoma - therapy | Breast Neoplasms - pathology | Colonic Neoplasms - pathology | Urinary Bladder Neoplasms - therapy | Brain Neoplasms - therapy | Radiotherapy, Conformal | Aged | Small Cell Lung Carcinoma - therapy | Melanoma - therapy | Biochemistry | Apoptosis | Index Medicus
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 6, pp. 747 - 756
Journal Article
Lancet, The, ISSN 0140-6736, 2011, Volume 378, Issue 9809, pp. 2104 - 2111
Journal Article
BJU International, ISSN 1464-4096, 03/2014, Volume 113, Issue 2, pp. 7 - 12
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2013, Volume 85, Issue 5, pp. 1375 - 1382
Purpose To extract and study comprehensive spatial-temporal18 F-labeled fluorodeoxyglucose ([18 F]FDG) positron emission tomography (PET) features for the... 
Radiology | Hematology, Oncology and Palliative Medicine | SURGERY | CHEMORADIOTHERAPY | POSITRON-EMISSION-TOMOGRAPHY | ONCOLOGY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | FDG PET | Fluorodeoxyglucose F18 - pharmacokinetics | Adenocarcinoma - pathology | Area Under Curve | Carcinoma, Squamous Cell - metabolism | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Male | Tomography, X-Ray Computed | Carcinoma, Squamous Cell - diagnostic imaging | Positron-Emission Tomography | Cisplatin - administration & dosage | Esophageal Neoplasms - pathology | Adenocarcinoma - metabolism | Fluorouracil - administration & dosage | Esophageal Neoplasms - metabolism | Multimodal Imaging - methods | Female | Spatio-Temporal Analysis | Retrospective Studies | Esophageal Neoplasms - therapy | Radiopharmaceuticals - pharmacokinetics | Carcinoma, Squamous Cell - therapy | Chemoradiotherapy, Adjuvant - methods | Adenocarcinoma - therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoadjuvant Therapy - methods | Adenocarcinoma - diagnostic imaging | Esophageal Neoplasms - diagnostic imaging | PET imaging | Nuclear radiation | Health aspects | Esophageal cancer | Adjuvant treatment | Cancer | Index Medicus | IMAGE PROCESSING | THERAPY | NEOPLASMS | ESOPHAGUS | POSITRON COMPUTED TOMOGRAPHY | FLUORODEOXYGLUCOSE | RADIOLOGY AND NUCLEAR MEDICINE | COMPUTERIZED TOMOGRAPHY | FLUORINE 18
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2014, Volume 90, Issue 5, pp. 1099 - 1107
Purpose To quantify the relationship between bone marrow (BM) response to radiation and radiation dose by using18 F-labeled fluorodeoxyglucose positron... 
Radiology | Hematology, Oncology and Palliative Medicine | CONSENSUS GUIDELINES | DELINEATION | GYNECOLOGIC MALIGNANCIES | CLINICAL TARGET VOLUME | ONCOLOGY | CONCURRENT CHEMOTHERAPY | INTENSITY-MODULATED RADIOTHERAPY | PELVIC RADIOTHERAPY | EMISSION-TOMOGRAPHY | PARAMETERS | COMPARTMENT | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Fluorodeoxyglucose F18 - pharmacokinetics | Chemoradiotherapy - adverse effects | Humans | Middle Aged | Tomography, X-Ray Computed - methods | Bone Marrow - radiation effects | Carcinoma, Squamous Cell - diagnostic imaging | Bone Marrow Cells - diagnostic imaging | Cisplatin - administration & dosage | Multimodal Imaging | Radiation-Sensitizing Agents - administration & dosage | Bone Marrow - metabolism | Aged, 80 and over | Adult | Female | Bone Marrow - diagnostic imaging | Retrospective Studies | Uterine Cervical Neoplasms - therapy | Radiotherapy Dosage | Acute Disease | Chemoradiotherapy - methods | Radiopharmaceuticals - pharmacokinetics | Radiotherapy, Intensity-Modulated - methods | Carcinoma, Squamous Cell - therapy | Bone Marrow Cells - radiation effects | Positron-Emission Tomography - methods | Blood Cell Count | Regression Analysis | Adenocarcinoma - therapy | Uterine Cervical Neoplasms - diagnostic imaging | Aged | Adenocarcinoma - diagnostic imaging | Bone Marrow Cells - metabolism | Cancer patients | Care and treatment | PET imaging | Radiation | Sport-utility vehicles | Standards | Cervical cancer | Cancer | Index Medicus | DIAGNOSIS | PATIENTS | NEOPLASMS | FLUORODEOXYGLUCOSE | BONE MARROW | RADIATION DOSES | TOXICITY | SKELETON | POSITRON COMPUTED TOMOGRAPHY | UPTAKE | RADIOLOGY AND NUCLEAR MEDICINE | BLOOD CELLS | RADIOTHERAPY | FLUORINE 18
Journal Article
JAMA, ISSN 0098-7484, 04/2012, Volume 307, Issue 15, pp. 1611 - 1620
Journal Article